COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,280 Articles (22,759 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 2453: Articles 24521-24530  | Next

Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy
Patterson, E. I., Elia, G., Grassi, A., Giordano, A., Desario, C., Medardo, M., Smith, S. L., Anderson, E. R., Lorusso, E., Lucente, M. S., Lanave, G., Lauzi, S., Bonfanti, U., Stranieri, A., Martella, V., Solari Basano, f., Barrs, V. R., Radford, A. D., Hughes, G. L., Paltrinieri, S., Decaro, N.
10.1101/2020.07.21.214346 — Posted: 2020-07-21 Discussion: Onsite | Offsite
Single cell RNA sequencing of blood antigen-presenting cells in severe Covid-19 reveals multi-process defects in antiviral immunity
Saichi, M., Ladjemi, M. Z., Korniotis, S., Rousseau, C., Ait-Hamou, Z., Massenet, L., Amblard, E., Noel, F., Marie, Y., Bouteiller, D., Medvedovic, J., Pene, F., Soumelis, V.
10.1101/2020.07.20.212837 — Posted: 2020-07-21 Discussion: Onsite | Offsite
Molecular mechanism of SARS-CoV-2 cell entry inhibition via TMPRSS2 by Camostat and Nafamostat mesylate
Hempel, T., Raich, L., Olsson, S., Azouz, N. P., Klingler, A. M., Rothenberg, M. E., Noe, F.
10.1101/2020.07.21.214098 — Posted: 2020-07-21
Intranasal Immunization with a Lentiviral Vector Coding for SARS-CoV-2 Spike Protein Confers Vigorous Protection in Pre-Clinical Animal Models
MAJLESSI, L., Ku, M.-W., Bourgine, M., Authie, P., Lopez, J., Nemirov, K., Moncoq, F., Noirat, A., Vesin, B., Nevo, F., Blanc, C., Souque, P., Simon, E., Tabbal, H., Mouquet, H., Anna, F., Martin, A., Escriou, N., Charneau, P.
10.1101/2020.07.21.214049 — Posted: 2020-07-21
A global survey on changes in the supply, price and use of illicit drugs and alcohol, and related complications during the 2020 COVID-19 pandemic
Farhoudian, A., Radfar, S. R., Mohaddes Ardabili, H., rafei, p., ebrahimy, m., Khojasteh zonoozi, A., A J De Jong, C., vahidi, m., yunesian, m., Kouimtsidis, C., arunogiri, s., hansen, h., Brady, k. T., potenza, m. N., ISAM-PPIG Global Survey Consortium, , Baldacchino, A. M., Ekhtiari, H.
10.1101/2020.07.16.20155341 — Posted: 2020-07-21
Multi-site co-mutations and 5'UTR CpG immunity escape drive the evolution of SARS-CoV-2
Zhang, J., Kang, J., Liu, M., Han, B., Li, L., He, Y., Yi, Z., Chen, L.
10.1101/2020.07.21.213405 — Posted: 2020-07-21 Discussion: Onsite
Discovery of potential imaging and therapeutic targets for severe inflammation in COVID-19 patients
Lee, H., Im, H.-J., Na, K. J., Choi, H.
10.1101/2020.07.20.213082 — Posted: 2020-07-21
Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates
Fahlberg, M. D., Blair, R. V., Doyle-Meyers, L. A., Midkiff, C. C., Zenere, G., Russell-Lodrigue, K. E., Monjure, C. J., Haupt, E. H., Penney, T. P., Lehmicke, G., Threeton, B. M., Golden, N., Datta, P. K., Roy, C. J., Bohm, R. P., Maness, N. J., Fischer, T., Rappaport, J., Vaccari, M.
10.1101/2020.07.21.213777 — Posted: 2020-07-21 Discussion: Onsite | Offsite
Humoral Response Dynamics Following Infection with SARS-CoV-2
Grandjean, L., Saso, A., Ortiz, A., Lam, T., Hatcher, J., Thistlethwaite, R., Harris, M., Best, T., Johnson, M., Wagstaffe, H., Ralph, E., Mai, A., Colijn, C., Breuer, J., Buckland, M., Gilmour, K., Goldblatt, D., The Co-Stars Study Team
10.1101/2020.07.16.20155663 — Posted: 2020-07-21
The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat raTG13
Liu, S., Selvaraj, P., Lien, C., Wu, W. W., Chou, C.-K., Wang, T.
10.1101/2020.07.20.213280 — Posted: 2020-07-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).